Europe Cell Culture Market

Europe Cell Culture Market is worth $14.23 billion by 2030

The report "Europe Cell Culture Market by Product [Consumable {Media, Sera, Reagent, Vessel (Roller Bottle, Flask, Cell Factory)}, Equipment {Bioreactor, Centrifuge, Filtration, Incubator, Freezer}], Application [mAb, Vaccine, CGT], End User - Forecast to 2030" is projected to grow from USD 8.50 billion in 2025 and to reach USD 14.23 billion by 2030, at a Compound Annual Growth Rate (CAGR) of 10.8% during the forecast period.

  

Browse 500 market data Tables and 40 Figures spread through 450 Pages and in-depth TOC on "Europe Cell Culture Market by Product [Consumable {Media, Sera, Reagent, Vessel (Roller Bottle, Flask, Cell Factory)}, Equipment {Bioreactor, Centrifuge, Filtration, Incubator, Freezer}], Application [mAb, Vaccine, CGT], End User - Forecast to 2030"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/europe-cell-culture-market-16082383.html

The Europe cell culture market is being driven by increasing government and private funding for cell-based research across the region. The adoption of emerging cell culture technologies and single-use systems is enhancing operational efficiency and flexibility in labs. Rising development and commercialization of monoclonal antibodies, biosimilars, and advanced therapy medicinal products are fueling demand. Additionally, the growing prevalence of infectious diseases in Europe is boosting the need for reliable cell culture platforms for diagnostics and therapeutics research.  

The consumables segment accounted for the dominant share in 2024 of the Europe cell culture market, by product.

By product, the Europe cell culture market is divided into consumables and equipment. In 2024, the consumables segment held the largest revenue share, driven by recurring demand for products such as culture media, reagents, flasks, and plates essential for ongoing research and biopharma production. Consumables are widely used across applications, including drug development, diagnostics, and tissue engineering, ensuring consistent market demand. Their relatively low cost, ease of use, and high turnover compared with equipment further contributed to the segment’s dominance. Additionally, the growing focus on high-throughput screening and advanced cell-based assays has reinforced reliance on consumables in laboratories across Europe.

The pharmaceutical and biotechnology companies segment is expected to be the fastest-growing end user segment in the forecast period.

By?‍?‌‍?‍‌?‍?‌‍?‍‌ end user, the market has been divided into pharmaceutical and biotechnology companies, hospitals and diagnostic laboratories, research and academic institutes, and other end users. Pharmaceutical and biotechnology companies were the largest contributors to the market in 2024, and this segment is also expected to grow at the highest rate in the coming years. The primary reason is that these companies are the main end users of cell culture products in drug discovery, biologics development, and clinical research. To meet their needs, these companies are heavily engaged in cell-based assays, high-throughput screening, and large-scale production of therapeutic proteins. Therefore, they continue to drive demand for consumables and equipment. In addition, the remarkable growth in vaccine, monoclonal antibody, and gene therapy development has made pharma and biotech the largest consumers of cell culture products in the region.

During the forecast period, Germany is anticipated to be the fastest-growing country in the Europe cell culture market.

The Europe cell culture market is divided into Germany, the UK, France, Italy, Spain, and the rest of Europe. Germany accounted for the largest share of the European cell culture market in 2024 and is expected to post the highest growth rate as well. Germany's strong demand for cell culture products has been driven by the presence of pharmaceutical companies in Germany, along with their robust investment in R&D. Germany's initiatives in developing biologics, regenerative medicine, and innovative drugs are also supporting the progress of this market. Another reason for Germany's dominance in this regional market is its well-established laboratory infrastructure, supported by adequate government funding and support in the life sciences research.

Key companies active in the Europe cell culture market include Thermo Fisher Scientific (US), Sartorius AG (Germany), and Merck KGaA (Germany), along with other regional and global companies.

Don’t miss out on business opportunities in Europe Cell Culture Market . Speak to our analyst and gain crucial industry insights that will help your business grow.

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter LinkedIn and Facebook .

Contact:
Mr. Rohan Salgarkar

MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/

Europe Cell Culture Market Size,  Share & Growth Report
Report Code
BT 9790
PR Published ON
11/29/2025
Choose License Type
BUY NOW
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Europe Cell Culture Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2026 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status
...

Digital Virtual Assistant - MarketsandMarkets

Home